TX-803

N/A

Report date: 2023/12/01 09:55:38
NME

Base Information

Drug NameTX-803
Drug Alias NameK-80003TX-803
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsRetinoid X receptor modulators
TargetsRetinoid X receptorPI3-kinase class I
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanford Burnham Prebys Medical Discovery Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTarrex Biopharma INC
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A